Ingrid Caras's Biography

Ingrid Caras, Senior Science Officer, California Institute for Regenerative Medicine

Dr. Ingrid Caras is a Senior Science Officer at the California Institute for Regenerative Medicine (CIRM) where she is involved in developing and implementing CIRM’s scientific programs. Prior to joining CIRM in September, 2009, she held the positions of Executive Director of Preclinical and Clinical Development Sciences and Senior Director of Bioanalytical Sciences at PDL Biopharma, where she oversaw a multi-functional department responsible for preclinical development of therapeutic antibodies and for the non-clinical portions of early clinical trials. In this role, she participated in strategy development for development programs in oncology and immunology and contributed to multiple IND filings and early clinical trials.

Before joining PDL Biopharma in 2003, Dr. Caras spent 5-years as Director of Cell Biology and Development Sciences at Eos Biotechnology, and 14-years at Genentech, initially as a Scientist and later as a Senior Scientist. Dr. Caras has extensive experience in both basic research as well as drug development and has worked in a number of diverse areas that include immunology, cell and molecular biology, cancer and neuroscience. She was principal consultant at IWC Bioscience and provided consulting services to the pharmaceutical industry, particularly in the area of immunogenicity of biologics.

Dr. Caras earned a B.Sc (Hons) degree from the University of the Witwatersrand in Johannesburg, South Africa and a Ph.D. from the Hebrew University of Jerusalem in Israel. She did post-doctoral training at Harvard University and at the University of California, San Francisco.

From Ballot Box to Bedside – Advancing Stem Cell Therapies, the California Institute for Regenerative Medicine Experience

Tuesday, 23 April 2013 at 13:45

Add to Calendar ▼2013-04-23 13:45:002013-04-23 14:45:00Europe/LondonFrom Ballot Box to Bedside – Advancing Stem Cell Therapies, the California Institute for Regenerative Medicine ExperienceClinical Translation of Stem Cells Summit in Palm Springs, CA, USAPalm Springs, CA, USASELECTBIOenquiries@selectbiosciences.com

Advancing science into therapies for patients is a complex and expensive path to travel. The uncertainty of success, particularly for innovative technologies, makes the funding of the translational steps towards and into the clinic, particularly challenging. This keynote will address the role the California Institute for Regenerative Medicine (CIRM) is playing in advancing stem cell science into the clinic and will provide information on the scope of programs, initiatives, and funding opportunities to help investigators from academia and companies make progress in their research.
Created in 2004 through the passage of Proposition 71 by voters in California, CIRM’s funding began in late 2006, focusing on CIRM’s mission to advance stem cell science towards therapies for patients with chronic disease and injuries. CIRM’s first 5 years set priorities based on establishing a strong foundation for leadership in stem cell research, seeding the entire field with discoveries using a variety of stem cell-based platforms, resulting in over $1.5 billion in 560 awards to 60 institutions/companies, publication of more than 1,200 journal articles, construction of 12 dedicated stem cell facilities, recruitment of more than 130 stem cell researchers to the state, and 75 translational projects in more than 30 therapeutic areas.
The focus for the next 5 years is on driving the science to clinical trials to generate evidence of therapeutic benefit for patients and on engaging industry in strategic partnerships to facilitate commercialization of therapies, while maintaining a pipeline of discovery including the basic science, which has the potential to fundamentally transform the field and medicine.

Add to Calendar ▼2013-04-22 00:00:002013-04-23 00:00:00Europe/LondonClinical Translation of Stem Cells SummitClinical Translation of Stem Cells Summit in Palm Springs, CA, USAPalm Springs, CA, USASELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors